Brain-Protein Study Could Lead To New Epilepsy Drugs

Written epilepsy diagnosis, with pills.
Print icon

Research identifying the role of a specific protein in the brain in triggering epileptic seizures could spark creation of a new family of medications to help patients with the disease, according to Dr. Gabriel Martz,  director of the Epilepsy Center at the Hartford HealthCare Ayer Neuroscience Institute.

The research, published in a recent issue of the academic journal Nature Communications, suggests that the protein collybindin, previously not thought to be relevant in the brain activity that activates or inhibits seizures, could actually play a role. A new medication, he says, could target the collybindin or its binding site in the brain to help curb seizures.

“We have many drugs on the market but most work in fairly similar ways,” Dr. Martz says. “This could lead to a new way of approaching the problem and of reducing cortical excitability, which many people think is the route of the problem of seizures.”

More than 50 million people in the world, and 3.4 million Americans, have epilepsy, making it one of the most widespread neurological conditions, according to the World Health Organization. In a healthy brain, nerve cells send electrical signals to each other. In parts of the brain of someone with epilepsy, abnormally high levels of electrical signals disrupt normal neurological function.

The research, conducted by neuroscientists at the University of Nevada, Las Vegas, expands the understanding of the signaling between neurons in epilepsy. Regulating the proteins in the brain that control cell signaling may lead to better therapies for stopping or preventing seizures entirely.

“This is a new piece in a big and age-old puzzle,” Dr. Martz says. “It is a stepping-off point for other research that will likely teach us more about how the brain works and may help improve the treatment for seizures, depending on whether medications that work on this protein can be identified and would be safe to take.”

The researchers also connected collybindin with anxiety, which Dr. Martz explains is because many signaling pathways in the brain affect multiple aspects of human functions and emotions.

“This protein seems to be involved in pathways for seizures and anxiety, in that the mice they developed with abnormalities of this protein had those problems,” he says. “It proves it can be relevant.”

For more information about treatment for epilepsy available at Hartford HealthCare, click here.

 


What's New

Flu Season

Here’s What’s in Your Flu Vaccine: Will It Work This Season?

Wasn’t it just yesterday that we were sunning ourselves at Hammonasset Beach? Actually, yes it was, but now it’s officially fall and we only care about one thing — the coming flu season. Predicting the severity of a flu season isn’t like predicting which team will win more football games, the...

Heart & aspirin.

Baby Aspirin a Day for Your Heart? Not For Everyone

While about 50 percent of older American adults take aspirin regularly to ward off heart disease, a new study reveals that the practice may actually cause more harm than good for healthy people. Dr. Paul Thompson, chief of cardiology and physician co-director of the Hartford HealthCare Heart & Vascular Institute,...

MitraClip.

Study: MitraClip Device a ‘Game-Changer’ for Heart-Failure Patients

Until now, patients with serious heart failure caused by leaky valves were treated so they felt a little better but the disease relentlessly stunted their life expectancy relentlessly. Recent research published in the New England Journal of Medicine, however,  gives hope to these patients, according to Dr. Sabet Hashim, chair...

Pharmacist

Report: Up to 75 Percent of Patients Don’t Take Meds as Prescribed

“Devastating” and “staggering (toll)” are adjectives used by officials with the National Council for Behavioral Health’s Medical Director Institute, or MDI, on its recent report showing a grave lack of compliance to medication prescriptions. Noncompliance with medication regimens — when people do not take prescription drugs as prescribed by their...


Kids, Social Media and Body Image

Raising teens to have a positive body image isn’t easy. And it seems to have become more complicated in the age of Snapchat and Instagram, where selfies can be filtered to perfection. Plastic surgeons have even reported that patients are visiting their practices with filtered social media images and asking...


Assessing the Hereditary Risk of Cancer

A new hereditary cancer risk assessment program is helping identify specific cancers in women and men across Connecticut. Hartford HealthCare nurse practitioner Meghan Burgess explains the importance of this program. Q: Why is it so important to have this type of assessment program? A: We’re identifying women at risk for...


What is Precision Medicine in Breast Cancer Treatment?

Precision medicine allows doctors to treat patients based on their individual biology. Dr. Camelia Lawrence is the director of breast surgery at the Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut and MidState Medical Center. She explains how precision medicine is used in treating breast cancer.  Q: What is precision medicine? A:...